Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RADIX 2 RENAL ARTERY STENT Evaluation of Safety and Performance in Everyday Clinical Practice: Post-Market Retrospective Study.

NCT05612438 is registered in ClinicalTrials.gov with CID S.p.A. as lead sponsor.

NCT NCT05612438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05612438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RADIX 2 RENAL ARTERY STENT Evaluation of Safety and Performance in Everyday Clinical Practice: Post-Market Retrospective Study.
Lead sponsor
CID S.p.A.
Phase
Observational
Overall status
Unknown status
Start date
March 3, 2023
Completion date
August 30, 2023
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal artery stenosis, renal failure